Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check17 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page updates from v3.0.1 to v3.0.2, removing the old revision tag and the 'Back to Top' element. No substantive content changes are indicated.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of relevant publications, including a significant study on cabozantinib for advanced adrenocortical carcinoma. Additionally, several terms related to genetic testing and health services have been added, while some previous location and cancer classification terms have been removed.SummaryDifference6%
- Check60 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.